Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity'?

Nat Rev Drug Discov. 2012 Sep;11(9):730; author reply 730. doi: 10.1038/nrd3503-c1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Chemical Industry / standards*
  • Drug Industry / standards*
  • Humans
  • Information Dissemination*